跳至主要内容
临床试验/JPRN-UMIN000011183
JPRN-UMIN000011183已完成未知

Analysis of the effect of oral nutritional supplement or branched chain amino acid (BCAA) on liver cirrhotic patients with less than 3.5 g/dl of serum albumin level. - Effect of oral nutritional supplement or BCAA on liver cirrhotic patients with less than 3.5 g/dl of serum albumin level.

Kanazawa Medical University0 个研究点目标入组 40 人开始时间: 2013年7月13日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients who are taking branched chain amino acid or oral nutritional supplement for liver failure. 2.Patients treated with albumin preparation. 3.Patients with refractory ascites. 4.Patients with history of hypersensitive against drugs. 5.Patients with liver cancer. 6.Patient with serious complications such as renal failure. 7.Patients who are heavy drinker more than 5 years. 8.Patient with refractory diabetes mellitus. 9.Patients who are pregnant or breastfeeding. 10.Patients whom cannot be obtained a written informed consent. 11.Patients judged to be inappropriate for the study by the investigator.

研究者

相似试验

Analysis of the effect of oral nutritional... | 临床试验